arrow
S

See-Tong Pang

College of Medicine
H指数:30
被引数:4,044

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Systematic Biopsy Core Number on Clinically Significant Prostate Cancer Detection and Complications in MRI-Ultrasound Fusion Biopsy: A Retrospective Cohort Study

系统活检芯数对MRI-超声融合活检中临床显著性前列腺癌检出及并发症的影响:一项回顾性队列研究

2026-08-280
OA
GWAS Study Identifies 3-SNP Risk Variants of PNPLA3/SAMM50 Linked to HCC Development in Individuals with Non-viral Liver Diseases

全基因组关联研究识别出PNPLA3/SAMM50的3个单核苷酸多态性风险变异,这些变异与非病毒性肝病患者中肝细胞癌的发生相关。

2025-11-110
OAAI
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies

台湾精准医学计划提供了一个队列用于大规模研究

Nature
IF48.5
2025-10-150
PRE
Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan

恩扎卢特胺与阿比特龙在转移性去势抵抗性前列腺癌患者中的比较有效性与安全性:一项来自台湾的全国性登记注册队列研究

2025-10-070
OA
Preoperative ECOG performance status as a predictor of outcomes in upper tract urothelial cancer surgery
2025-03-260
OAAI
Polygenic height prediction for the Han Chinese in Taiwan

台湾汉族多基因身高预测

2025-02-050
OA
Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade

马兜铃酸相关肾细胞癌表现出独特的肿瘤免疫微环境,有利于对免疫检查点阻断的反应

2024-10-030
OA
Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study

223镭在转移性去势抵抗性前列腺癌患者中的真实安全性和有效性: 前瞻性观察性RAPIT研究的中期分析

2024-06-262
PRE